Marc E Norman
Examiner (ID: 14641, Phone: (571)272-4812 , Office: P/3744 )
Most Active Art Unit | 3744 |
Art Unit(s) | 3763, 3744, 2163 |
Total Applications | 2635 |
Issued Applications | 2141 |
Pending Applications | 200 |
Abandoned Applications | 293 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18628589
[patent_doc_number] => 20230287463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => PROCESS TO BACTERIALLY DECOMPOSE ORGANIC WASTE MATERIAL
[patent_app_type] => utility
[patent_app_number] => 18/100827
[patent_app_country] => US
[patent_app_date] => 2023-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5701
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18100827
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/100827 | PROCESS TO BACTERIALLY DECOMPOSE ORGANIC WASTE MATERIAL | Jan 23, 2023 | Pending |
Array
(
[id] => 18495432
[patent_doc_number] => 20230217932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => FUNCTIONAL MICROBIAL-DERIVED PREPARATIONS
[patent_app_type] => utility
[patent_app_number] => 18/153139
[patent_app_country] => US
[patent_app_date] => 2023-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1499
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18153139
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/153139 | FUNCTIONAL MICROBIAL-DERIVED PREPARATIONS | Jan 10, 2023 | Pending |
Array
(
[id] => 18391688
[patent_doc_number] => 20230159906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => Protease-controlled Secretion and Display of Intercellular Signals
[patent_app_type] => utility
[patent_app_number] => 17/985624
[patent_app_country] => US
[patent_app_date] => 2022-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7708
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 266
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17985624
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/985624 | Protease-controlled Secretion and Display of Intercellular Signals | Nov 10, 2022 | Pending |
Array
(
[id] => 18268162
[patent_doc_number] => 20230089404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => Bioassisted Process For Selective Conversion Of Alkane Rich Refinery Stream
[patent_app_type] => utility
[patent_app_number] => 17/931994
[patent_app_country] => US
[patent_app_date] => 2022-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5327
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17931994
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/931994 | Bioassisted Process For Selective Conversion Of Alkane Rich Refinery Stream | Sep 13, 2022 | Pending |
Array
(
[id] => 18295964
[patent_doc_number] => 20230105650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => Analytical Assessment Of Bacterial Endotoxin
[patent_app_type] => utility
[patent_app_number] => 17/930491
[patent_app_country] => US
[patent_app_date] => 2022-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5398
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17930491
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/930491 | Analytical Assessment Of Bacterial Endotoxin | Sep 7, 2022 | Pending |
Array
(
[id] => 18077748
[patent_doc_number] => 20220403360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => LIGASE FUSION PROTEINS AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/813467
[patent_app_country] => US
[patent_app_date] => 2022-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31161
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17813467
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/813467 | LIGASE FUSION PROTEINS AND APPLICATION THEREOF | Jul 18, 2022 | Pending |
Array
(
[id] => 18871447
[patent_doc_number] => 11859236
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-02
[patent_title] => Method for detecting L-serine based on cysteine desulfurase-containing living
[patent_app_type] => utility
[patent_app_number] => 17/811600
[patent_app_country] => US
[patent_app_date] => 2022-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 2606
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17811600
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/811600 | Method for detecting L-serine based on cysteine desulfurase-containing living | Jul 10, 2022 | Issued |
Array
(
[id] => 17958699
[patent_doc_number] => 20220339279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => RECOMBINANT PROTEINS, COMPOSITIONS, VECTORS, KITS, AND METHODS FOR IMMUNIZING AGAINST, AND TESTING FOR EXPOSURE TO, SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2
[patent_app_type] => utility
[patent_app_number] => 17/721709
[patent_app_country] => US
[patent_app_date] => 2022-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21292
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17721709
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/721709 | RECOMBINANT PROTEINS, COMPOSITIONS, VECTORS, KITS, AND METHODS FOR IMMUNIZING AGAINST, AND TESTING FOR EXPOSURE TO, SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 | Apr 14, 2022 | Pending |
Array
(
[id] => 17930162
[patent_doc_number] => 20220325287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => THANOTRANSMISSION POLYPEPTIDES AND THEIR USE IN TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/710965
[patent_app_country] => US
[patent_app_date] => 2022-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67765
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17710965
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/710965 | THANOTRANSMISSION POLYPEPTIDES AND THEIR USE IN TREATING CANCER | Mar 30, 2022 | Pending |
Array
(
[id] => 17274759
[patent_doc_number] => 20210380957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/403236
[patent_app_country] => US
[patent_app_date] => 2021-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61352
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -112
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17403236
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/403236 | CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF | Aug 15, 2021 | Pending |
Array
(
[id] => 17126498
[patent_doc_number] => 20210301266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => ENGINEERED IMINE REDUCTASES AND METHODS FOR THE REDUCTIVE AMINATION OF KETONE AND AMINE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/343058
[patent_app_country] => US
[patent_app_date] => 2021-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45380
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 221
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17343058
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/343058 | ENGINEERED IMINE REDUCTASES AND METHODS FOR THE REDUCTIVE AMINATION OF KETONE AND AMINE COMPOUNDS | Jun 8, 2021 | Pending |
Array
(
[id] => 17053579
[patent_doc_number] => 20210263013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => USE OF EOMESODERMIN TO DETERMINE RISK OF ALLOGRAFT REJECTION
[patent_app_type] => utility
[patent_app_number] => 17/245716
[patent_app_country] => US
[patent_app_date] => 2021-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9061
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17245716
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/245716 | USE OF EOMESODERMIN TO DETERMINE RISK OF ALLOGRAFT REJECTION | Apr 29, 2021 | Pending |
Array
(
[id] => 16854975
[patent_doc_number] => 20210155720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => Method for Preparing Hyaluronan Odd-numbered Oligosaccharides by Double Enzyme Hydrolysis
[patent_app_type] => utility
[patent_app_number] => 17/168261
[patent_app_country] => US
[patent_app_date] => 2021-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4797
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17168261
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/168261 | Method for Preparing Hyaluronan Odd-numbered Oligosaccharides by Double Enzyme Hydrolysis | Feb 4, 2021 | Pending |
Array
(
[id] => 16793260
[patent_doc_number] => 20210123077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => ADENO-ASSOCIATED VIRUS VECTOR MEDIATED GENE THERAPY FOR OPHTHALMIC DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/080078
[patent_app_country] => US
[patent_app_date] => 2020-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15051
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17080078
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/080078 | ADENO-ASSOCIATED VIRUS VECTOR MEDIATED GENE THERAPY FOR OPHTHALMIC DISEASES | Oct 25, 2020 | Pending |
Array
(
[id] => 16854911
[patent_doc_number] => 20210155656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => Methods for purification of polypeptides using polysorbates
[patent_app_type] => utility
[patent_app_number] => 17/080505
[patent_app_country] => US
[patent_app_date] => 2020-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21339
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17080505
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/080505 | Methods for purification of polypeptides using polysorbates | Oct 25, 2020 | Pending |
Array
(
[id] => 17897400
[patent_doc_number] => 20220307062
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => ALLULOSE EPIMERASE VARIANT, METHOD OF PRODUCING THE SAME, AND METHOD OF PRODUCING ALLULOSE USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/295627
[patent_app_country] => US
[patent_app_date] => 2020-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6704
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17295627
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/295627 | Allulose epimerase variant, method of producing the same, and method of producing allulose using the same | Sep 24, 2020 | Issued |
Array
(
[id] => 17595694
[patent_doc_number] => 20220145268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => ENGINEERED GLUCOSE DEHYDROGENASES AND METHODS FOR THE REDUCTIVE AMINATION OF KETONE AND AMINE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/600357
[patent_app_country] => US
[patent_app_date] => 2020-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37630
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17600357
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/600357 | ENGINEERED GLUCOSE DEHYDROGENASES AND METHODS FOR THE REDUCTIVE AMINATION OF KETONE AND AMINE COMPOUNDS | Apr 22, 2020 | Pending |
Array
(
[id] => 17506437
[patent_doc_number] => 20220099540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => METHODS AND SYSTEMS FOR ASSESSING BIOELECTRIC PATTERNS
[patent_app_type] => utility
[patent_app_number] => 17/439768
[patent_app_country] => US
[patent_app_date] => 2020-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8782
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17439768
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/439768 | METHODS AND SYSTEMS FOR ASSESSING BIOELECTRIC PATTERNS | Mar 19, 2020 | Pending |
Array
(
[id] => 17595661
[patent_doc_number] => 20220145235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => STORAGE LIQUID FOR MAMMALIAN CELLS
[patent_app_type] => utility
[patent_app_number] => 17/438025
[patent_app_country] => US
[patent_app_date] => 2020-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20257
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17438025
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/438025 | STORAGE LIQUID FOR MAMMALIAN CELLS | Mar 12, 2020 | Pending |
Array
(
[id] => 17595685
[patent_doc_number] => 20220145259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => Liver Tissue Model Constructs and Methods for Providing the Same
[patent_app_type] => utility
[patent_app_number] => 17/438031
[patent_app_country] => US
[patent_app_date] => 2020-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6587
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17438031
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/438031 | Liver Tissue Model Constructs and Methods for Providing the Same | Mar 12, 2020 | Pending |